Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Food-symptom diaries can generate personalized lifestyle advice for managing gastrointestinal symptoms: A pilot study.

Clevers E, Nordqvist A, Törnblom H, Tack J, Masclee A, Keszthelyi D, Van Oudenhove L, Simrén M.

Neurogastroenterol Motil. 2020 Feb 7:e13820. doi: 10.1111/nmo.13820. [Epub ahead of print]

PMID:
32031756
2.

Quality of life in irritable bowel syndrome: Authors' reply.

Mujagic Z, Weerts ZZRM, Vork L, Leue C, Kruimel JW, Hesselink M, Muris JWM, Jonkers DMAE, Masclee AAM, Keszthelyi D.

Neurogastroenterol Motil. 2020 Jan;32(1):e13729. doi: 10.1111/nmo.13729. No abstract available.

PMID:
31854094
3.

Percutaneous endoscopic versus radiologic gastrostomy for enteral feeding: a retrospective analysis on outcomes and complications.

Strijbos D, Keszthelyi D, Gilissen LPL, Lacko M, Hoeijmakers JGJ, van der Leij C, de Ridder RJJ, de Haan MW, Masclee AAM.

Endosc Int Open. 2019 Nov;7(11):E1487-E1495. doi: 10.1055/a-0953-1524. Epub 2019 Oct 23.

4.

Prucalopride: An Opportunity to Simultaneously Address Gastroparesis and Chronic Constipation.

Keszthelyi D.

Am J Gastroenterol. 2019 Dec;114(12):1919. doi: 10.14309/ajg.0000000000000415. No abstract available.

PMID:
31592785
5.

Normal colonic transit time predicts the outcome of colonic manometry in patients with chronic constipation-an exploratory study.

Vork L, van Avesaat MHP, van Hoboken EA, Kruimel JW, Conchillo JM, Keszthelyi D, Masclee AAM.

Int J Colorectal Dis. 2019 Oct;34(10):1819-1822. doi: 10.1007/s00384-019-03376-1. Epub 2019 Aug 31.

PMID:
31471700
6.

Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.

Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D.

Gastroenterology. 2020 Jan;158(1):123-136. doi: 10.1053/j.gastro.2019.08.026. Epub 2019 Aug 27.

PMID:
31470006
7.

Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.

Botschuijver S, van Diest SA, van Thiel IAM, Saia RS, Strik AS, Yu Z, Maria-Ferreira D, Welting O, Keszthelyi D, Jennings G, Heinsbroek SEM, Elferink RPO, Schuren FHJ, de Jonge WJ, van den Wijngaard RM.

Sci Rep. 2019 Aug 29;9(1):12530. doi: 10.1038/s41598-019-49096-y.

8.

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome.

Weerts ZZRM, Vork L, Mujagic Z, Keszthelyi D, Hesselink MAM, Kruimel J, Leue C, Muris JWM, Jonkers DMAE, Masclee AAM.

Neurogastroenterol Motil. 2019 Aug;31(8):e13629. doi: 10.1111/nmo.13629. Epub 2019 May 22.

9.

Therapeutic strategies in gastroparesis: Results of stepwise approach with diet and prokinetics, Gastric Rest, and PEG-J: A retrospective analysis.

Strijbos D, Keszthelyi D, Smeets FGM, Kruimel J, Gilissen LPL, de Ridder R, Conchillo JM, Masclee AAM.

Neurogastroenterol Motil. 2019 Jun;31(6):e13588. doi: 10.1111/nmo.13588. Epub 2019 Apr 4.

10.

Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets?

Csekő K, Beckers B, Keszthelyi D, Helyes Z.

Pharmaceuticals (Basel). 2019 Mar 30;12(2). pii: E48. doi: 10.3390/ph12020048. Review.

11.

Intraintestinal Delivery of Tastants Using a Naso-Duodenal-Ileal Catheter Does Not Influence Food Intake or Satiety.

Klaassen T, Alleleyn AME, van Avesaat M, Troost FJ, Keszthelyi D, Masclee AAM.

Nutrients. 2019 Feb 23;11(2). pii: E472. doi: 10.3390/nu11020472.

12.

Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.

Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK.

Sci Transl Med. 2018 Dec 19;10(472). pii: eaap8914. doi: 10.1126/scitranslmed.aap8914.

PMID:
30567928
13.

The Experience Sampling Method-Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder.

Vork L, Mujagic Z, Drukker M, Keszthelyi D, Conchillo JM, Hesselink MAM, van Os J, Masclee AAM, Leue C, Kruimel JW.

Neurogastroenterol Motil. 2019 Jan;31(1):e13515. doi: 10.1111/nmo.13515. Epub 2018 Nov 20.

PMID:
30460734
14.

The Effect of an Encapsulated Nutrient Mixture on Food Intake and Satiety: A Double-Blind Randomized Cross-Over Proof of Concept Study.

Alleleyn AME, van Avesaat M, Ripken D, Bleiel SB, Keszthelyi D, Wilms E, Troost FJ, Hendriks HFJ, Masclee AAM.

Nutrients. 2018 Nov 17;10(11). pii: E1787. doi: 10.3390/nu10111787.

15.

Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method.

Smeets FGM, Keszthelyi D, Vork L, Tack J, Talley NJ, Simren M, Aziz Q, Ford AC, Conchillo JM, Kruimel JW, Van Os J, Masclee AAM.

Neurogastroenterol Motil. 2019 Feb;31(2):e13496. doi: 10.1111/nmo.13496. Epub 2018 Nov 4.

PMID:
30393939
16.

A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers.

Weerts ZZRM, Keszthelyi D, Vork L, Aendekerk NCP, Frijlink HW, Brouwers JRBJ, Neef C, Jonkers DMAE, Masclee AAM.

Adv Ther. 2018 Nov;35(11):1965-1978. doi: 10.1007/s12325-018-0802-1. Epub 2018 Oct 4.

PMID:
30284674
17.

A Systematic Review and Meta-Analysis on Outcomes and Complications of Percutaneous Endoscopic Versus Radiologic Gastrostomy for Enteral Feeding.

Strijbos D, Keszthelyi D, Bogie RMM, Gilissen LPL, Lacko M, Hoeijmakers JGJ, van der Leij C, de Ridder R, de Haan MW, Masclee AAM.

J Clin Gastroenterol. 2018 Oct;52(9):753-764. doi: 10.1097/MCG.0000000000001082.

PMID:
29924079
18.

Percutaneous endoscopic gastrostomy under conscious sedation in patients with amyotrophic lateral sclerosis is safe: an observational study.

Strijbos D, Hofstede J, Keszthelyi D, Masclee AAM, Gilissen LPL.

Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1303-1308. doi: 10.1097/MEG.0000000000000959.

PMID:
28877087
19.

Editorial: Clinical Implications of Diagnosing Irritable Bowel Syndrome: Do All Roads Need to Lead to Rome?

Keszthelyi D, Ringel Y.

Am J Gastroenterol. 2017 Jun;112(6):900-902. doi: 10.1038/ajg.2017.115.

PMID:
28572651
20.

Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease.

Rinsma NF, Farré R, Troost FJ, Elizalde M, Keszthelyi D, Helyes Z, Masclee AA, Conchillo JM.

Int J Mol Sci. 2017 May 19;18(5). pii: E1091. doi: 10.3390/ijms18051091.

Supplemental Content

Loading ...
Support Center